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By using two molecular probes, we demonstrate that only 4% of total phosphatidylethanolamine (PtdEtn) in the
plasma membrane (PM) of a human pathogenic yeast,Candida albicans,i present in its external half. Evidence is
presented to show that the availability of PtdEtn could be related to the expression of a multidrug transporterCDRl
of C.albicans,and the process is energy-dependent. A homozygousCDRI di ruptant strain of C.albicanshows
almost 23% reduction in the external labelling of PtdEtn. This report shows that, similar to human MDRs, yeast
multidrugtransporter could also be involvedin aminophospholipidtranslocation.' -= -~ - ",
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INTRODUCTION
..
Membrane phospholipids are asymmetrically
distributed across the plasma membrane (PM) of
a variety of cells (Diaz and Schroit, 1996;
Williamson and Schlegel, 1994).Most of the phos-
phatidylethanolamine (PtdEtn) and phosphatidyl-
serine (PtdSer) are located on the inner leaflet
of the lipid bilayer, while phosphatidylcholine
(PtdCho) and other lipids are predominantly
localized on the outer half of the bilayer (Schroit
and Zwaal, 1991). The asymmetrical distribution
of membrane lipids is very specific and the loss of
this asymmetry has been linked to various physio-
logical processes (Keanet al.,1997; Diaz and
Schroit, 1996;Tanget al.,1996; Utsugiet al., 1991;
Herrmann and Devaux, 1990).
Overexpression of a 170 kDa glycoprotein (P-
glycoprotein) is involved in multidrug resistance
(MDR). Such MDR proteins belong to a group of
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membrane transporters known as ABC (ATP
binding cassette) transporters, which are widely
distributed throughout the evolutionary scale
(Prasadet al.,1996; Hyde t al.,1990; Higgins,
1992; Lewis, 1994). The completion of the S.
eerevisiaegenome project has revealed that there
are 29 putative ABC proteins, which could be
homologues of MDRs (Decottignies and Goffeau,
1997). The multidrug transporters in yeast not
only include members of the ABC family but also
a family of membrane facilitators (MFS), which
are probably antiporters (Goffeauet al., 1997;
Balzi and Goffeau, 1994). In addition, regulatory
networks of PDR (pleiotropic drug resistance)
genes, backed by transcription regulators, are also
well characterized (Balzi and Goffeau, 1994, 1995).
The studies involving MDR in yeast have
attracted much attention, since they are good
model systems and some of them are also patho-
genic.Candida albieansis a dimorphic and oppor-
tunistic human pathogen (Gowet al., 1994;
Prasad, 1991), which is naturally more resistant to
several drugs than S.eerevisiae(Prasadet al.,
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1996). In recent years, the incidence of C.albieans
cells acquiring resistance to azoles and polyenes
has increased alarmingly (Prasadet al., 1996;
Van den Bossche, 1995). We had earlier cloned
and sequenced a multidrug transporter,CDRl
(Candidadrug resistance) of C.albieans,which is a
homologue of S.eerevisiaemultidrug efflux pump
PDR5 (Prasadet al.,1995b; Balzi and Goffeau,
1994, 1995). A few more homologues ofCDRl
have been identified recently in C.albieans(Walsh
et al.,1997; Balanet al.,1997; Sanglardet al.,
1997) and many genes specific to fluconazole and
benomyl resistance have also been characterized
(Alarcoet al.,1997; Prasadet al.,1995; Prasad
et al., 1996).
Earlier, human Mdrlp and Mdr3p and
mouse mdr2p have been shown to have flippase
activity, which mediates phospholipid translo-
cation directed towards the exoplasmic leaflet of
the lipid bilayer (Ruetz and Gros, 1994; Bosch
et al.,1997; Van Helvoorte al.,1996). Recently,
Keanet al.(1997) have shown that translocation
of PtdEtn in S.eerevisiaeis controlled byPDRl
andPDR3 and identified two new alleles,tp l-l
(dominant) andtpe2-1(semidominant) forPDRI
andPDR3,respectively. Pdrlp and Pdr3p are tran-
scription regulators which control the expression
of several genes including ABC transporters
like PDR5 and SNQ2 (Balzi and Goffeau, 1994,
1995).
Asymmetrical distribution of phospholipids is
not restricted to mammalian cells. The PM of S.
eerevisiaecells is also asymmetric with regard to
aminophospholipids and is controlled by an
energy-dependent amino phospholipid translocase
(Kean et al.,1997; Tanget al.,1996). This com-
munication, for the first time, by using two
molecular probes, shows that C.lbieansPM is
asymmetric, where PtdEtn is predominantly con-
fined to the cytoplasmic leaflet of PM. We further
show that the expression ofCDRl, a multidrug
resistance ABC transporter gene, affects the
availability of PtdEtn in the outer half of the PM
in an energy-dependent process, and present
evidence that Cdrl p could be a phospholipid
translocator.
MATERIALS AND METHODS
Materials
Yeast media were obtained from Difco
lauoratories (USA). All other chemicals were
purchased from Sigma Chemicals Co. (USA).
Pr coated silica gel G-60 F TLC plates were
obtained from E. Merck.
Strains and culture conditions
Candida albieansATCC 10261 was grown in
YEPD medium (2% bactopeptone, 1% bactoyeast
extract and 2% glucose) (Jethwaneyet al., 1997).
C. albieansstrains CAF2-1(Llura3::imm434/
URA3), DSY449 (Lledrl::hisG/L1edrl::hisG),
DSY1025 (Lledrl::hisG/L1edrl::hisG, Lledr2::hisG/
Lledr2::hisG)were also maintained and grown in
YEPD medium, as described earlier (Sanglard
et al., 1997). S.eerevisiaeJG436 (Mat a,
PDR5::Tn5, leu2, met5, ura3-52, mak71, KRBl)
was a kind gift from Dr J. Golin, Catholic
University of America, Washington, DC (Prasad
et al.,1995b). S.eerevisiaeAD 1234568 (Mat a,
pdrl-3, hisl, ura3, pdr5Ll, snq2Ll,pdrlOLl, pdrllLl,
pdrl5Ll, yorlL1, yeflL1),was a kind gift from A.
Decottignies, E. Balzi and A. Goffeau, Universite
Catholique de Louvain, Belgium. Both the strains,
which were hypersensitive to cycloheximide, were
transformed with theCDRI gene by a method
described earlier (Prasadet al.,1995b). The result-
ing transformants S-12 and AD-CDRI were
hyper-resistant to cycloheximide and to many
other unrelated drugs and were expressingCDRl,
as was evident from their Northern analysis (data
not hown).
Trinitrobenzenesulphonie acid (TN BS) labelling
TNBS labelling was done essentially by the
method described earlier (Balasubramanian and
Gupta, 1996). C.albieanscells were harvested in
mid-log phase by centrifuging at 3000 rpm for
5 min at 4°C and washed two or three times with
buffer A (100 mM potassium phosphate, 5 mM
EDT A, pH 7'5). The harvested cells (0'6 g wet
weight) were resuspended in 5 ml of buffer B
(100 mM potassium phosphate and 600 mM KCI,
pH 8'2) and kept at 4°C with gentle swirling. An
equal volume of indicated concentration of TNBS
(freshly prepared and chilled) in buffer B was
added to the cell suspension. After indicated time,
the reaction was stopped by adding equal volume
of buffer C (200 mM potassium acetate, 600 mM
KCI, pH 4'5). The suspension was centrifuged and
washed two or three times with buffer C until
the colour of free TNBS disappeared from the
sup rnatant.
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Table I. Percentage of total and labelled PtdEtn in different hosts and their transformants, using two different
probes, TNBS and fluorescaminea.
Strains Genotypes
Percentage
PtdEtn of
total
phospholipids
Percentage labelled PtdEtn
of total PtdEtnb
TNBS Fluorescamine
"Percentage values represent mean of at least 15-20 determinations.
b20 mM TNBS or 15.6 mM ftuorescamine was used to label non-permeabilized cells. The incubation time of labelling for TNBS was
15 h while it was a few seconds in the case of ftuorescamine. The derivatized PtdEtn was separated and quantitated as described
in 'Materials and Methods'.
cTransformant carryingCaMDRl (MFS type) gene of C.albicans.
Fluorescamine labelling
Fluorescamine labelling of C.albicanscells was
done essentially as described by Balasubramanian
and Gupta (1996). Cells were harvested and
washed as described above for TNBS labelling.
Cells (0'6 g wet weight), were suspended in 3 ml
of buffer B. Indicated concentrations of fluor-
escamine in dehydrated DMSO were added drop-
wise to the cell suspension with constant gentle
swirling. After 30 s the reaction was stopped by
adding equal volume of 1M ammonia in 600 mM
KC!. The cells were centrifuged and washed at 4°C
three to four times until the colour of the dye
disappeared from the supernatant.
Lipid extraction and thin layer chromatography
Lipids were extracted as described earlier
(Ibrahim and Ghannoum, 1996; Koul and Prasad,
1996). Solvents used in the first and second dimen-
sions were chloroform:methanol:30% ammonium
hydroxide (65:25:6 v/v) and chloroform:water:
methanol:glacial acetic acid:acetone (45:4:8:9:16
v/v), respectively. Resolved phospholipids and
derivatized phospholipid were scraped off from
plates and their phosphate content was estimated.
Isolation of total RNA and Northern analysis
Total RNA isolation from C.albicanscells and
Northern analysis were performed as described
elsewhere (Sambrooket al.,1989; Carlson and
Botstein, 1992).
pH-Induced germ tubeformation
Bud and mycelia were generated by procedure
described elsewhere (Kauret al.,1988). C.albicans
10261 cells were inoculated into 25 ml of amino
acid-rich medium (pH 6'8) in plastic Erlenmeyer
flasks, and grown at 25°C up to the late log phase
of growth (5 x 107 cells/ml). For zinc depletion,
cells were inoculated into a fresh flask and main-
tained at 2YC at stationary phase for 48 h, result-
ing in a final concentration of 2.5 x 108 cells/m!.
St tionary phase G 1 singlets (I' 5 x 109 cells/ml)
wer lightly sonicated at a power of 5 /l peak to
peak amplitude, using an MSE Ultrasonic
Disintegrater at 2--4°Cfor 1min, and incubated in
300 ml nutrient media in 500 ml Erlenmeyer flasks.
Cells were grown at 37°C at either pH 4,5 or
pH 6,5 to induce bud or hypha formation, respect-
ively. Aliquots were removed at different time
S. cerevisiae
JG436 Mata, PDR5::Tn5, leu2, met5, ura3-52, mak71, KRB126.47::1: 0,50 18.7 ::I:0.2818.3 ::I:0,4
S-12 JG436 harbouringCDR1 29.25::1: 0.7124.4 ::I:1.2 24.1 ::I:0.1
NC34c JG436 harbouringCaMDR1 22.1 ::I: 1.28 18.7::I:0,72 19.1 ::1:0.56
AD Mata, pdr1-3, his1, ura3, pdr5£l, snq2£l, 28.17::1: 1.28 13-9 ::I:0.11 12.7 ::I:0,60
pdrlO£l, pdrll£l, pdr15£l, yorl£l, ycf1£l
AD-CDRI AD harbouring CDR1 27.77::I: 1.44 23,56::1: 0,6 23.23::1: 0,38
C. albicans
ATCC I0261 15.16::1:0,714,3 ::I:0.14 4.2 ::I:0.28
CAF 2-1 £lura3::imm434IURA3 22.62::I: 0,05 - 7.33::1:0.11
DSY 449 £lcdr1::hisGI £lcdr1::hisG 22.64::1: 1.33 - 5.68::1: 0.18
DSY 1025 £lcdr1::hisGI £lcdr1::hisG, £lcdr2::hisGI £lcdr2::hisG 22.90::1: 0-41 - 4.4 ::I:0.26
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intervals, and cell divergence was microscopically
examined.
RESULTS
Labelling of plasma membrane PtdEtn of intact
C. albicans cells
TNBS has been widely used in determining
aminophospholipid distribution in membranes of
different cell types. Recently, Balasubramanian
and Gupta (1996) have shown the suitability of
TNBS and fluorescamine for labelling the external
PtdEtn of yeast PM. It is evident from Table I that
both the probes were equally efficient in labelling
the exposed PtdEtn of different yeast strains. The
suitability of these probes was further established
when we checked their impermeability under our
labelling conditions. Under experimental con-
ditions, the probes were impermeable to yeast cells
and could only label the PtdEtn of the external
leaflet. If cells were permeabilized, the same
reagents could label up to 80% of the aminophos-
pholipids, including PtdSer (it was not labelled in
normal cells by either of the reagents, since most
of PtdSer tS localized in the cytoplasmic leaflet).
Under the microscope, permeabilized cells labelled
with fluorescamine showed dispersed fluorescence,
while the latter was localized to the exteriors of
non-permeabilized cells (data not shown). The
results of the present study thus confirm that
TNBS and fluorescamine can be used to label
PtdEtn of C.albicansand S.cerevisiaecells.
As can be seen from Figure la, b, PtdEtn could
be labelled by both the probes in a concentration-
dependent manner. In purified PM of C.albicans,
of the total phospholipids present, '" 15% was
PtdEtn (data not shown) and only ",4% of it was
labelled with both the aminophospholipid labelling
reagents in intact cells. This would mean that, out
of total PtdEtn in non-permeabilized C.albicans
cells, only'" 4% is available for external labelling
and the rest ('" 96%) is localized in the inner leaflet
of PM. It must be pointed out that about 10-15 h
were required for TNBS (20 mM)labelling (Figure
la, inset), while fluorescamine (15'6 mM) could
label the amino phospholipid in 30 s (data not
shown). Since the labelling with fluorescamine is
very rapid, it is expected to cause much less
erturbation in the lipid organization, and
therefore was routinely used in the following
experiments (Rawyleret al.,1984).
PtdEtn translocation from inner to outer leaflet is
energy dependent and protein-mediated
The movement of PtdEtn across PM of
C. albicanscould be prevented if cells were
preincubated with energy inhibitors like sodium
azide and sodium orthovanadate. Figure 2a,
depicts labelling of PtdEtn in the presence of these
in ibitors. Sodium azide, which is a mitochondrial
ATP synthesis inhibitor, and sodium ortho-
vanadate, which is a typical inhibitor of
PM-ATPase, if added prior to labelling of PtdEtn
with fluorescamine, resulted in reduced labelling.
Almost 58-80% labelling of PtdEtn was inhibited
by 10mM of azide and 20 mM of vanadate. NEM
(10 mM),which blocks free thiol groups of proteins
and thus prevents protein-mediated processes,
w en added before labelling, was also able to
block PtdEtn labelling with fluorescamine by
about 52% (Figure 2a). If cells were starved of
glucose for 14h for the depletion of cellular ATP,
th labelling was reduced by 60%. However, if cells
w re repleted with glucose, the total labelling of
PtdEtn was again restored within 6 h. As shown
earli r, for S.cerevisiaecells (Balasubramanian
and Gupta, 1996) there may be an energy depen-
dent amino phospholipid translocase in C.albicans
which controls the movement of PtdEtn across the
two mono layers (Figure 2b). It must be mentioned
that the total phospholipid composition of C.
albicans,determined under various experimental
conditions, did not vary significantly (data not
shown).
Expression of CDRI is linked to PtdEtn
translocation
In order to ascertain whetherCDRI expression
could contribute in PtdEtn translocation, S.
ce visiaetransformant S-12, which was expressing
CDRl, was used to examine the PtdEtn distri-
buti n (Prasadet al.,1995b). Interestingly, in S-12
strain out of total PtdEtn, almost 24% of it was
lab lled by both fluorescamine and TNBS, as
Figure I. Percentage labelling of PtdEtn of plasma membrane ofCandida albicansATCC 10261 with (a) TNBS and (b)
fluorescamine. The inset (a) shows the optimum time required for a 20 mMTNBS labelling. The labelling was done as described in
Methods. Derivatized PtdEtn and other phospholipids were extracted and quantified as mentioned in 'Materials and Methods'.
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compared to its host strain, JG436 ('" 19%) lacking
CDRI and also having disruptedPDR5, which is
a homologue ofCDRI (Table I). ThatCDRI
could be involved in PtdEtn translocation was
further confirmed when another transformant of
S. cerevisiae(NC34), which was expressing a non-
ABC transporter benomyl resistance(CaMDRI)
gene, a membrane facilitator (Prasadet al.,per-
sonal communication) was checked for PtdEtn
localization. It was observed that", 19%of PtdEtn
was labelled in NC34 as in its host strain JG436
(Table 1). It must be pointed out that only 4%
of total PtdEtn could be labelled in C.albicans
10261 cells, while 18-24% of it was labelled in
S. cerevisiaestrains.
The expression ofCDRI is morphologically
regulated. As can be seen from Figure 3a that
CDRI transcript is higher in mycelial form than in
the bud form of C.albicans(Figure 3a and 3b).
Interestingly, PtdEtn, in the outer leaflet of
membrane, was also found to be much higher in
the mycelial form as compared to bud form
(Figure 3c). It is pertinent to mention that there
was no significant change in phospholipid com-
position including that of PtdEtn between bud or
mycelial forms of C.albicanscells (data not
shown). Thus, the expression ofCDRI appears to
be linked to PtdEtn translocation.
S.cerevisiaestrain S-12 having disruptedPDR5,
is known to harbour several other ABC trans-
porters, which might mask the function of Cdrl p
(Decottignies and Goffeau, 1997). We, therefore,
transformed S.cerevisiae(ADI234568) which was
(called as AD hereafter, in this paper) constructed
by A. Decottignies (in A. Goffeau's group), where-
in seven ABC transporter genes, e.g.PDR5(pleio-
tropic drug resistance gene),PDRJO, PDRll,
PDRI5, SNQ2 (Saccharomycesnitroquinoline-N-
oxide resistance gene),ycn (yeast cadmium fac-
tor gene) andYORI (yeast oligomycin resistance
gene) were disrupted (Decottignieset al., 1998).
AD strain was transformed with theCDRI gene
(Prasadet al.,1995b) and the resulting transform-
ant was designated as AD-COR I. Both the strains
were subjected to fluorescamine labelling. The
labelling of PtdEtn was about 24% in AD-COR I,
as compared to its host strain AD where only
13-14% of PtdEtn could be labelled with fluor-
escamine (Table I). Similar to C.albicanscells
(Figure 2a, b), the translocation of PtdEtn
mediated byCDRI was energy dependent as the
labelling with fluorescamine was inhibited by azide
a d vanadate. NEM could also prevent the trans-
location of this aminophospholipid in AD-COR 1
strain (Figure 4a). ATP depletion of cells clearly
prevented the translocation of PtdEtn which could
be restored upon its repletion (Figure 4b). A
homozygous disruptedCDRI strain of C.albicans
DSY449 was used to check if the non-availability
of functional Cdr Ip could affect the availability of
xternal PtdEtn (Sanglardet al.,1997). It is evi-
dent from Table 1 that DSY449 has about 23%
less of external PtdEtn than its parent strain
CAF2-1. Interestingly, a double disrupt ant of
CDRI and CDR2 (a homologue ofCDRl)
DSYI025, showed even less (",40% less as com-
pared to parent strain) of PtdEtn in the external
alf of PM (Table 1) suggesting the involvement
of both the ABC transporters in PtdEtn trans-
location. It should be mentioned that the differ-
ence in external labelling of PtdEtn in strain 10261
and CAF2-1 could be due to their genotypic
differences.
DISCUSSION
We have shown that PM of C.albicanscells is
asymmetric with regard to PtdEtn distribution.
Most of the PtdEtn was localized in inner leaflet
and only 4% of it was exposed to external leaflet.
The distribution of PtdEtn was affected if cells
were preincubated with energy inhibitors prior to
the labelling with fluorescamine. It was apparent
from our results that availability of PtdEtn in
outer half was mediated by an energy-dependent
process. In this regard it is pertinent to mention
about recent reports where aminophospholipid
translocase activities in various systems including
yeast cells have been shown to control the amino-
phospholipidmovement(Decottignieset al.,1998;
Kean et al.,1997; Balasubramanian and Gupta,
1996; Tanget al.,1996). However, the presence
of such translocase was not demonstrated in
Figure 2. Effect of (a) different inhibitors, (b) depletion and repletion of cellular ATP on PtdEtn of the plasma membrane of
Candida albicansATCC 10261 with fluorescamine (15'6 mM).Cells were incubated with the indicated concentrations of sodium
azide (2 h), sodium orthovanadate (30 min) and NEM (10 min). For ATP depletion, cells were starved for 14 h and were repleted
with the addition of 2% glucose for 4-6 h. All the treated cells were subjected to fluorescamine labelling, as described in 'Materials
and Methods'.
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Figure 3. (a) Levels ofCDRI transcript in bud and mycelial
forms. (b) The normalized value ofCDRI transcript after
consideringAcn (actin) as internal control. Details of
Northern analysis and RNA isolation were similar to those
described earlier. (c) Percentage labelling of PtdEtn with
fluorescamine (15.6 mM) in bud and mycelial forms. The bud
and mycelial forms were formed by pH-regulated dimorphism,
as described in 'Materials and Methods'. The fully differenti-
ated population of cells as bud or mycelial forms was taken for
Northern and lipid analyses.
C. albieanscells. This report for the first time
confirms that flippase activities could be a com-
mon phenomenon in lower eukaryotes.
We present evidence to demonstrate thatCDRI,
which is a homologue ofPDR5, has flippase
activity which translocates PtdEtn to the outer
leaflet of the membrane. First, there is an energy-
dependent movement of PtdEtn in S.eerevisiae
transformants which expressCDRI of C.albieans.
This translocation was even more evident when
CDRI was expressed in the AD strain of S.eerevi-
siae(AD-CDR1), which was deleted in seven ABC
transporters. Interestingly, the host AD strain
showed some reduction in fluorescamine labelling
after treatment with energy inhibitors and also
after depletion of ATP (data not shown). This
could be due to the presence of other, as yet
unidentified, phospholipid translocators in S.
eerevisiae,including the known translocator Drs2p
which is a P-type transport ATPase involved in PS
translocation (Tanget al.,1996; Keanet al., 1997).
Second, the involvement of Cdrl p in phospholipid
translocation was further evident from the fact that
the increased amount of PtdEtn in the outer leaflet
of PM of mycelial form correlated well withCDRI
expression, which was also more pronounced in the
mycelial than in the bud form of C.albieans.The
decrease in the availability of PtdEtn in the outer
half of PM of a homozygousCDRI disruptant also
suggests that it might be involved in PtdEtn trans-
location. It is interesting to note that, similar to
mammalian MDRs (e.g.MDRI and MDR2),
CDR2,a homologue ofCDRI, may also contribute
to phospholipid translocation. However, this
aspect remains to be investigated. This was further
confirmed when S.eerevisiaetransformant express-
ing a non-ABC transporter(CaMDRI), of C.
albieanswas found to have no affect on the PtdEtn
distribution pattern between the two leaflets.
Our results, therefore, suggest that the PtdEtn
translocation is linked to an ABC transporter
Cdrl p of C.albieans.Whether Cdrl p, like human
Mdrlp, is a general phospholipid translocator or
specific to aminophospholipids remains to be re-
solved (Ruetz and Gros, 1994; Boschet al., 1997;
Van Helvoortet al.,1996). As mentioned earlier,
the contribution of other ABC transporters, like
CDR3 (Balanet al., 1997; White, 1997) in C.
albieans,and of others as yet uncharacterized
transporters which may be involved in phospho-
lipid translocation, can not be excluded from these
results. What the mechanism of the movement of
phospholipid from the outer to the cytoplasmic
leaflet in C.albieanscells is, and how many pro-
teins control it, are some of the questions which
remain to be resolved.
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Figure 4. Percentage labelling of PtdEtn with ftuorescamine (15.6 mM), (a) in the presence of inhibitors
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preincubation with inhibitors, etc., were similar to those described in the caption for Figure 2.
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